Researchers reviewed nearly 500 studies to understand what environmental factors cause or worsen vitiligo, a skin condition where people lose skin color in patches. They found that certain medications (especially cancer drugs), chemical exposures, and infections like COVID-19 are the strongest triggers. Stress, sun damage, and lifestyle factors like smoking and sleep also appeared to play a role, though scientists need more research to fully understand how. This comprehensive review helps doctors and patients identify what might be causing vitiligo and how to potentially prevent it from getting worse.
The Quick Take
- What they studied: What things in our environment, daily lives, and medical treatments trigger vitiligo (a condition where skin loses its color) or make it worse?
- Who participated: Scientists reviewed 496 different research studies involving thousands of people with vitiligo from around the world, published up to August 2024.
- Key finding: Certain medications used to treat cancer, particularly immune checkpoint inhibitors, caused vitiligo in 7-25% of patients who took them. Chemicals like phenol (used in some products) and COVID-19 infection also increased vitiligo risk, though the increases were smaller.
- What it means for you: If you take certain cancer medications or work with specific chemicals, you should be aware vitiligo is a possible side effect worth monitoring. While stress, sun exposure, and lifestyle factors seem important, scientists still need better evidence about exactly how much they contribute.
The Research Details
This was a systematic review, which means researchers searched two major medical databases (PubMed and Embase) for all studies about vitiligo and environmental triggers published through August 2024. They found 8,377 studies initially and carefully selected 496 that met their quality standards. The researchers followed strict international guidelines (called PRISMA) to make sure they did this fairly and transparently, and they registered their plan ahead of time so no one could accuse them of cherry-picking results.
The studies they included ranged from small case reports (stories about individual patients) to large observational studies (where researchers follow groups of people over time). They also included clinical trials (where people are randomly assigned to different treatments) and reports from drug safety monitoring systems. Because the studies were so different from each other in design and how they measured results, the researchers couldn’t combine all the numbers into one big analysis. Instead, they summarized what they found by grouping similar studies together and describing the patterns they saw.
This approach is important because vitiligo is complicated—it’s not caused by just one thing. By looking at hundreds of studies together, researchers can see which triggers have the strongest evidence behind them and which ones need more investigation. This helps doctors give better advice to patients about what to avoid or watch out for.
The main strength of this review is that it looked at a huge number of studies and followed strict scientific rules. However, most of the studies included were observational (watching what happens naturally) rather than experiments where researchers control conditions. This means we can see connections between things, but we can’t always prove one thing directly caused another. Also, different studies measured vitiligo differently and studied different populations, making it hard to compare results directly. The researchers were honest about these limitations.
What the Results Show
The strongest evidence came from medications. Immune checkpoint inhibitors—drugs used to treat melanoma (a serious skin cancer)—caused vitiligo in 7-25% of patients taking them. This is a very high rate and was the most consistent finding across multiple studies. Phenol-based chemicals, which are used in some industrial and medical products, were also consistently linked to killing the cells that make skin color (melanocytes).
COVID-19 infection showed a modest but measurable increase in vitiligo risk, with studies suggesting about an 11% higher chance of developing the condition after infection. Importantly, the COVID-19 vaccines did not increase vitiligo risk—this is reassuring for people worried about vaccine side effects.
Many studies mentioned stress, physical trauma (like cuts or burns), sunburn, smoking, diet, and poor sleep as potential triggers. However, these factors had much weaker evidence—mostly from small studies or case reports rather than large, well-designed research. The researchers found 113 studies about stress alone, but many were low-quality, making it hard to draw firm conclusions.
Other medications besides cancer drugs were occasionally reported to trigger vitiligo, but the evidence was inconsistent. Some studies suggested certain infections besides COVID-19 might play a role, but this needs more research. The review also found that different populations might respond differently to the same triggers, suggesting that genetics and individual differences matter a lot.
This is the first comprehensive systematic review to look at all environmental factors (the ’exposome’) for vitiligo together. Previous research had looked at individual triggers separately, but this study shows how they fit together. The findings confirm what doctors already suspected about medications and chemicals but provide stronger evidence. The modest COVID-19 finding is relatively new and adds to our understanding of how infections might trigger autoimmune conditions.
The biggest limitation is that most studies were observational—researchers watched what happened but didn’t control conditions like in an experiment. This means we can see that two things are connected, but we can’t always prove one caused the other. Different studies used different ways to diagnose vitiligo and measure how severe it was, making comparisons difficult. Many studies were small, and some were just case reports about individual patients. The researchers couldn’t do a meta-analysis (combining all the numbers) because the studies were too different from each other. Finally, most research came from certain countries, so the findings might not apply equally to all populations worldwide.
The Bottom Line
If you’re taking immune checkpoint inhibitors for cancer treatment, discuss vitiligo risk with your doctor and monitor your skin carefully (HIGH confidence). Avoid or minimize exposure to phenol-based chemicals if possible (MODERATE-HIGH confidence). If you have COVID-19, be aware that vitiligo risk may slightly increase, though it remains uncommon (MODERATE confidence). For stress, sun protection, smoking cessation, and sleep improvement—these are good health practices anyway, and they may help with vitiligo, though the evidence is still developing (LOW-MODERATE confidence).
People taking cancer medications should definitely pay attention to these findings. Workers exposed to industrial chemicals should be aware of potential risks. People with a family history of vitiligo or those who already have vitiligo should understand these triggers to help prevent worsening. People recovering from COVID-19 should monitor for new skin changes. Everyone else can benefit from the general healthy lifestyle recommendations, though vitiligo risk remains relatively uncommon in the general population.
Drug-related vitiligo can appear within weeks to months of starting medication. Chemical exposure effects may develop over months to years depending on exposure level. COVID-19-related vitiligo typically appears within weeks to a few months after infection. Lifestyle factor effects (stress, sleep, sun exposure) likely develop over weeks to months of consistent exposure. Once vitiligo appears, stopping the trigger (like changing medications) may help prevent progression, but existing color loss typically doesn’t return quickly.
Want to Apply This Research?
- If taking medications or exposed to chemicals: Take weekly photos of your skin in consistent lighting and note any new white patches or changes in existing ones. Track location, size, and spread rate. Also log medication changes, chemical exposures, stress levels, and sleep hours to identify personal patterns.
- Create a ‘vitiligo trigger log’ in your app. When you notice a flare or new patches, work backward to identify what changed in the past 2-4 weeks: Did you start a new medication? Increase stress? Have poor sleep? Get significant sun exposure? Over time, your personal pattern will emerge, helping you avoid your specific triggers.
- Set monthly reminders to review your skin photos and trigger log. Look for correlations between your activities/exposures and vitiligo changes. Share this data with your dermatologist at appointments. If you’re on medication that might trigger vitiligo, schedule skin checks every 3 months rather than waiting for problems to develop.
This review summarizes scientific evidence about vitiligo triggers but is not medical advice. Vitiligo is a complex condition with multiple causes, and triggers vary greatly between individuals. If you have vitiligo, are considering medications that might trigger it, or notice new skin changes, consult a dermatologist or healthcare provider for personalized evaluation and treatment. Do not stop taking prescribed medications without medical guidance. This information is current as of August 2024 and should be updated as new research emerges.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.